Laparoscopic adrenalectomy.
Laparoscopic adrenalectomy (LA) was first described in the literature in 1992, and has become the preferred method for the removal of benign functioning and non-functioning tumors of the adrenal gland <12 cm. The objectives of the present study are to review the experience of LA gained since it was first done in 1992 and to critically evaluate its effectiveness for the surgical management of endocrine hypertension; specifically pheochromocytoma, aldosteronoma and Cushing's syndrome and disease, as opposed to open adrenalectomy. The benefits of minimally invasive techniques for the removal of the adrenal gland include decreased requirements for analgesics, improved patient satisfaction, shorter hospital stay and recovery time when compared to open surgery. LA can be performed safely for bilateral disease and may become the standard of care for malignant tumors. Current limitations are operator-dependent and not a factor of limitations of minimally invasive techniques. A thorough pre-operative work-up is key for differentiating the various cases of hypertension and adequate pre-operative treatment is paramount when indicated.
Gumbs
Andrew A
AA
New York-Presbyterian Hospital, Division of Laparoscopic and Bariatric Surgery and Department of Surgery, Joan and Sanford I. Weill Medical College of Cornell University, PO Box 294, New York, NY 10021, USA.
Gagner
Michel
M
D000236:Adenoma / Q000378:metabolism / Q000601:surgery; D000310:Adrenal Gland Neoplasms / Q000378:metabolism / Q000601:surgery; D000315:Adrenalectomy / Q000379:methods* / Q000401:mortality; D000450:Aldosterone / Q000378:metabolism; D000075202:Contraindications; D003289:Convalescence; D003480:Cushing Syndrome / Q000601:surgery; D006801:Humans; D010535:Laparoscopy / Q000379:methods* / Q000401:mortality; D007902:Length of Stay; D017060:Patient Satisfaction; D010673:Pheochromocytoma / Q000601:surgery
D000450:Aldosterone